Managing Chronic Pain in Cancer Survivors Prescribed Long-Term Opioid Therapy: A National Survey of Ambulatory Palliative Care Providers

Jessica S. Merlin, Kanan Patel, Nicole Thompson, Jennifer Kapo, Frank Keefe, Jane Liebschutz, Judith Paice, Tamara Somers, Joanna L. Starrels, Julie Childers, Yael Schenker, Christine S. Ritchie

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Context: Chronic pain, or pain lasting more than three months, is common among cancer survivors, who are often prescribed long-term opioid therapy (LTOT). Objective: Our objective was to explore palliative care providers’ experiences with managing chronic pain in cancer survivors prescribed LTOT, specifically in ambulatory palliative care settings, and their strategies for overcoming challenges. Methods: We recruited providers through leading national palliative care organizations who manage chronic pain in cancer survivors. Asked to consider only cancer survivors with chronic pain when responding, participants completed an online survey that included questions about use of opioid risk mitigation tools, confidence in addressing opioid misuse behaviors and discussing/recommending management approaches, and access to addiction treatment. Results: Of 157 participants, most were physicians (83%) or nurse practitioners (15%). Most reported using opioid risk mitigation tools such as urine drug testing (71%), opioid treatment agreements (85%), and practitioner database monitoring programs (94%). Participants were confident (7–8/10) managing the most commonly encountered opioid misuse behaviors (missing appointments, marijuana use, and using more opioids than prescribed) and in their ability to recommend nonpharmacologic and nonopioid pharmacologic treatments for chronic pain (10/10). They were least confident prescribing naloxone or managing addiction (5/10); only 27% reported having training or systems in place to address addiction. Only 13% had a waiver to prescribe buprenorphine. Conclusion: Palliative care providers are comfortable with many aspects of managing chronic pain in cancer survivors on LTOT, although challenges persist, including the lack of systems-based approaches and training in addiction treatment.

Original languageEnglish (US)
Pages (from-to)20-27
Number of pages8
JournalJournal of Pain and Symptom Management
Volume57
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Ambulatory Care
Palliative Care
Chronic Pain
Opioid Analgesics
Survivors
Neoplasms
Therapeutics
Surveys and Questionnaires
Buprenorphine
Aptitude
Nurse Practitioners
Cannabis
Naloxone
Appointments and Schedules
Urine
Databases
Physicians
Pain
Pharmaceutical Preparations

Keywords

  • ambulatory medicine
  • cancer pain
  • cancer survivor
  • opioids
  • Palliative care

ASJC Scopus subject areas

  • Nursing(all)
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Managing Chronic Pain in Cancer Survivors Prescribed Long-Term Opioid Therapy : A National Survey of Ambulatory Palliative Care Providers. / Merlin, Jessica S.; Patel, Kanan; Thompson, Nicole; Kapo, Jennifer; Keefe, Frank; Liebschutz, Jane; Paice, Judith; Somers, Tamara; Starrels, Joanna L.; Childers, Julie; Schenker, Yael; Ritchie, Christine S.

In: Journal of Pain and Symptom Management, Vol. 57, No. 1, 01.01.2019, p. 20-27.

Research output: Contribution to journalArticle

Merlin, JS, Patel, K, Thompson, N, Kapo, J, Keefe, F, Liebschutz, J, Paice, J, Somers, T, Starrels, JL, Childers, J, Schenker, Y & Ritchie, CS 2019, 'Managing Chronic Pain in Cancer Survivors Prescribed Long-Term Opioid Therapy: A National Survey of Ambulatory Palliative Care Providers', Journal of Pain and Symptom Management, vol. 57, no. 1, pp. 20-27. https://doi.org/10.1016/j.jpainsymman.2018.10.493
Merlin, Jessica S. ; Patel, Kanan ; Thompson, Nicole ; Kapo, Jennifer ; Keefe, Frank ; Liebschutz, Jane ; Paice, Judith ; Somers, Tamara ; Starrels, Joanna L. ; Childers, Julie ; Schenker, Yael ; Ritchie, Christine S. / Managing Chronic Pain in Cancer Survivors Prescribed Long-Term Opioid Therapy : A National Survey of Ambulatory Palliative Care Providers. In: Journal of Pain and Symptom Management. 2019 ; Vol. 57, No. 1. pp. 20-27.
@article{f52975fce0704bd58c91a0d842edc307,
title = "Managing Chronic Pain in Cancer Survivors Prescribed Long-Term Opioid Therapy: A National Survey of Ambulatory Palliative Care Providers",
abstract = "Context: Chronic pain, or pain lasting more than three months, is common among cancer survivors, who are often prescribed long-term opioid therapy (LTOT). Objective: Our objective was to explore palliative care providers’ experiences with managing chronic pain in cancer survivors prescribed LTOT, specifically in ambulatory palliative care settings, and their strategies for overcoming challenges. Methods: We recruited providers through leading national palliative care organizations who manage chronic pain in cancer survivors. Asked to consider only cancer survivors with chronic pain when responding, participants completed an online survey that included questions about use of opioid risk mitigation tools, confidence in addressing opioid misuse behaviors and discussing/recommending management approaches, and access to addiction treatment. Results: Of 157 participants, most were physicians (83{\%}) or nurse practitioners (15{\%}). Most reported using opioid risk mitigation tools such as urine drug testing (71{\%}), opioid treatment agreements (85{\%}), and practitioner database monitoring programs (94{\%}). Participants were confident (7–8/10) managing the most commonly encountered opioid misuse behaviors (missing appointments, marijuana use, and using more opioids than prescribed) and in their ability to recommend nonpharmacologic and nonopioid pharmacologic treatments for chronic pain (10/10). They were least confident prescribing naloxone or managing addiction (5/10); only 27{\%} reported having training or systems in place to address addiction. Only 13{\%} had a waiver to prescribe buprenorphine. Conclusion: Palliative care providers are comfortable with many aspects of managing chronic pain in cancer survivors on LTOT, although challenges persist, including the lack of systems-based approaches and training in addiction treatment.",
keywords = "ambulatory medicine, cancer pain, cancer survivor, opioids, Palliative care",
author = "Merlin, {Jessica S.} and Kanan Patel and Nicole Thompson and Jennifer Kapo and Frank Keefe and Jane Liebschutz and Judith Paice and Tamara Somers and Starrels, {Joanna L.} and Julie Childers and Yael Schenker and Ritchie, {Christine S.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jpainsymman.2018.10.493",
language = "English (US)",
volume = "57",
pages = "20--27",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Managing Chronic Pain in Cancer Survivors Prescribed Long-Term Opioid Therapy

T2 - A National Survey of Ambulatory Palliative Care Providers

AU - Merlin, Jessica S.

AU - Patel, Kanan

AU - Thompson, Nicole

AU - Kapo, Jennifer

AU - Keefe, Frank

AU - Liebschutz, Jane

AU - Paice, Judith

AU - Somers, Tamara

AU - Starrels, Joanna L.

AU - Childers, Julie

AU - Schenker, Yael

AU - Ritchie, Christine S.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Context: Chronic pain, or pain lasting more than three months, is common among cancer survivors, who are often prescribed long-term opioid therapy (LTOT). Objective: Our objective was to explore palliative care providers’ experiences with managing chronic pain in cancer survivors prescribed LTOT, specifically in ambulatory palliative care settings, and their strategies for overcoming challenges. Methods: We recruited providers through leading national palliative care organizations who manage chronic pain in cancer survivors. Asked to consider only cancer survivors with chronic pain when responding, participants completed an online survey that included questions about use of opioid risk mitigation tools, confidence in addressing opioid misuse behaviors and discussing/recommending management approaches, and access to addiction treatment. Results: Of 157 participants, most were physicians (83%) or nurse practitioners (15%). Most reported using opioid risk mitigation tools such as urine drug testing (71%), opioid treatment agreements (85%), and practitioner database monitoring programs (94%). Participants were confident (7–8/10) managing the most commonly encountered opioid misuse behaviors (missing appointments, marijuana use, and using more opioids than prescribed) and in their ability to recommend nonpharmacologic and nonopioid pharmacologic treatments for chronic pain (10/10). They were least confident prescribing naloxone or managing addiction (5/10); only 27% reported having training or systems in place to address addiction. Only 13% had a waiver to prescribe buprenorphine. Conclusion: Palliative care providers are comfortable with many aspects of managing chronic pain in cancer survivors on LTOT, although challenges persist, including the lack of systems-based approaches and training in addiction treatment.

AB - Context: Chronic pain, or pain lasting more than three months, is common among cancer survivors, who are often prescribed long-term opioid therapy (LTOT). Objective: Our objective was to explore palliative care providers’ experiences with managing chronic pain in cancer survivors prescribed LTOT, specifically in ambulatory palliative care settings, and their strategies for overcoming challenges. Methods: We recruited providers through leading national palliative care organizations who manage chronic pain in cancer survivors. Asked to consider only cancer survivors with chronic pain when responding, participants completed an online survey that included questions about use of opioid risk mitigation tools, confidence in addressing opioid misuse behaviors and discussing/recommending management approaches, and access to addiction treatment. Results: Of 157 participants, most were physicians (83%) or nurse practitioners (15%). Most reported using opioid risk mitigation tools such as urine drug testing (71%), opioid treatment agreements (85%), and practitioner database monitoring programs (94%). Participants were confident (7–8/10) managing the most commonly encountered opioid misuse behaviors (missing appointments, marijuana use, and using more opioids than prescribed) and in their ability to recommend nonpharmacologic and nonopioid pharmacologic treatments for chronic pain (10/10). They were least confident prescribing naloxone or managing addiction (5/10); only 27% reported having training or systems in place to address addiction. Only 13% had a waiver to prescribe buprenorphine. Conclusion: Palliative care providers are comfortable with many aspects of managing chronic pain in cancer survivors on LTOT, although challenges persist, including the lack of systems-based approaches and training in addiction treatment.

KW - ambulatory medicine

KW - cancer pain

KW - cancer survivor

KW - opioids

KW - Palliative care

UR - http://www.scopus.com/inward/record.url?scp=85058968561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058968561&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2018.10.493

DO - 10.1016/j.jpainsymman.2018.10.493

M3 - Article

C2 - 30342243

AN - SCOPUS:85058968561

VL - 57

SP - 20

EP - 27

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 1

ER -